Authors:
Alexopoulos, A
Kouroussis, C
Malamos, N
Kakolyris, S
Kalbakis, K
Kosmas, C
Mavroudis, D
Agelaki, S
Vlachonicolis, J
Sarra, E
Rigatos, G
Georgoulias, V
Citation: A. Alexopoulos et al., Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study, ANN ONCOL, 12(6), 2001, pp. 793-798
Authors:
Mavroudis, D
Papadakis, E
Veslemes, M
Tsiafaki, X
Stavrakakis, J
Kouroussis, C
Kakolyris, S
Bania, E
Jordanoglou, J
Agelidou, M
Vlachonicolis, J
Georgoulias, V
Citation: D. Mavroudis et al., A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, ANN ONCOL, 12(4), 2001, pp. 463-470
Authors:
Mavroudis, D
Malamos, N
Alexopoulos, A
Kourousis, C
Agelaki, S
Sarra, E
Potamianou, A
Kosmas, C
Rigatos, G
Giannakakis, T
Kalbakis, K
Apostolaki, F
Vlachonicolis, J
Kakolyris, S
Samonis, G
Georgoulias, V
Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215
Authors:
Georgoulias, V
Kouroussis, C
Androulakis, N
Kakolyris, S
Dimopoulos, MA
Papadakis, E
Bouros, D
Apostolopoulou, F
Papadimitriou, C
Agelidou, A
Hatzakis, K
Kalbakis, K
Kotsakis, A
Vardakis, N
Vlachonicolis, J
Citation: V. Georgoulias et al., Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial, J CL ONCOL, 17(3), 1999, pp. 914-920
Authors:
Kakolyris, S
Samonis, G
Koukourakis, M
Vlachonicolis, J
Kalbakis, K
Agelaki, S
Chalkiadakis, G
Sanidas, E
Tsiftsis, D
Georgoulias, V
Citation: S. Kakolyris et al., First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrolacetate in advanced breast cancer, AM J CL ONC, 22(3), 1999, pp. 273-277
Authors:
Sara, E
Kotsakis, A
Souklakos, J
Kourousis, C
Kakolyris, S
Mavromanolakis, E
Vlachonicolis, J
Georgoulias, V
Citation: E. Sara et al., Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4(+) cell proliferation, ANTICANC R, 19(1A), 1999, pp. 471-476